Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported an 11 percent year-over-year decrease in its fiscal second quarter revenues, which it attributed to a 16 percent drop in diagnostics segment sales.

Separately, the company announced today that it will acquire molecular diagnostics maker GenePOC for up to $120 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.